Johns Hopkins Hospital and School of Medicine, 600 N Wolfe St, Blalock 524, Baltimore, MD, USA; Deutsches Herzzentrum der Charité (DHZC), Charité - Universitätsmedizin Berlin, Department of Cardiology, Angiology and Intensive Care Medicine, Campus Virchow-Klinikum, Berlin, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Berlin, Berlin, Germany.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
J Cardiovasc Comput Tomogr. 2023 Sep-Oct;17(5):310-317. doi: 10.1016/j.jcct.2023.07.004. Epub 2023 Aug 3.
The coronary atheroma burden drives major adverse cardiovascular events (MACE) in patients with suspected coronary heart disease (CHD). However, a consensus on how to grade disease burden for effective risk stratification is lacking. The purpose of this study was to compare the effectiveness of common CHD grading tools to risk stratify symptomatic patients.
We analyzed the 5-year outcome of 381 prospectively enrolled patients in the CORE320 international, multicenter study using baseline clinical and cardiac computer-tomography (CT) imaging characteristics, including coronary artery calcium score (CACS), percent atheroma volume, "high-risk" plaque, disease severity grading using the CAD-RADS, and two simplified CAD staging systems. We applied Cox proportional hazard models and area under the curve (AUC) analysis to predict MACE or hard MACE, defined as death, myocardial infarction, or stroke. Analyses were stratified by a history of CHD. Additional forward selection analysis was performed to evaluate incremental value of metrics.
Clinical characteristics were the strongest predictors of MACE in the overall cohort. In patients without history of CHD, CACS remained the only independent predictor of MACE yielding an AUC of 73 (CI 67-79) vs. 64 (CI 57-70) for clinical characteristics. Noncalcified plaque volume did not add prognostic value. Simple CHD grading schemes yielded similar risk stratification as the CAD-RADS classification. Forward selection analysis confirmed prominent role of CACS and revealed usefulness of functional testing in subgroup with known CHD.
In patients referred for invasive angiography, a history of CHD was the strongest predictor of MACE. In patients without history of CHD, a coronary calcium score yielded at least equal risk stratification vs. more complex CHD grading.
冠状动脉粥样斑块负担是导致疑似冠心病(CHD)患者发生主要不良心血管事件(MACE)的主要因素。然而,目前尚缺乏关于如何对疾病负担进行分级以实现有效风险分层的共识。本研究旨在比较常见的 CHD 分级工具在对有症状患者进行风险分层方面的效果。
我们分析了国际多中心 CORE320 前瞻性研究中 381 例患者的 5 年预后,使用基线临床和心脏计算机断层扫描(CT)影像学特征,包括冠状动脉钙评分(CACS)、斑块体积百分比、“高危”斑块、CAD-RADS 疾病严重程度分级以及两种简化的 CAD 分期系统。我们应用 Cox 比例风险模型和曲线下面积(AUC)分析来预测 MACE 或硬 MACE,定义为死亡、心肌梗死或中风。分析按 CHD 病史进行分层。此外还进行了向前选择分析,以评估指标的增量价值。
临床特征是整个队列中 MACE 的最强预测因素。在无 CHD 病史的患者中,CACS 仍然是 MACE 的唯一独立预测因素,其 AUC 为 73(CI 67-79),而临床特征的 AUC 为 64(CI 57-70)。非钙化斑块体积没有增加预后价值。简单的 CHD 分级方案与 CAD-RADS 分类具有相似的风险分层效果。向前选择分析证实了 CACS 的重要作用,并揭示了功能测试在已知 CHD 亚组中的有用性。
在接受有创血管造影检查的患者中,CHD 病史是 MACE 的最强预测因素。在无 CHD 病史的患者中,冠状动脉钙评分的风险分层效果至少与更复杂的 CHD 分级相当。